← Back to catalogue

Infinion™ CX

FDA UDI

Class III (US FDA UDI)

by Boston Scientific Neuromodulation

Identity

Trade Name
Infinion™ CX FDA UDI
Generic Name
Implantable electrical stimulation system intraoperative test lead FDA UDI
Device Name
70cm 16 Contact Trial Lead Kit FDA UDI
Model / Reference
SC-2317-70E FDA UDI
Description
70cm 16 Contact Trial Lead Kit FDA UDI

Identifiers

Primary DI / UDI-DI
08714729861645 FDA UDI
PMA Number
P030017 FDA UDI
FDA Product Code
LGW FDA UDI
QRB FDA UDI
GMDN Term
Implantable electrical stimulation system intraoperative test lead FDA UDI

Classification

Device Class
Class III FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

Yes

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

Yes

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Implantable electrical stimulation system intraoperative test lead

Infinion™ CX by Boston Scientific Neuromodulation — Class III — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Implantable electrical stimulation system intraoperative test lead.

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI b2afaace-b4a2-4657-867c-1afbf3314062 35 fields · synced May 30, 2026